Establishing the clinical spectrum and pathogenicity of antibodies against dopamine receptors in autoimmune movement and psychiatric disorders

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1055322

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Dopamine plays a pivotal role in neurotransmission and the control of movement and behaviour. This project aims to define the clinical spectrum and pathogenicity of anti-dopamine receptor antibody mediated diseases. The identification of these antibodies in atypical presentations of common movement disorders would have widespread diagnostic and therapeutic implications, and suggests that selected patients might be amenable to targeted immunomodulatory therapy, thus improving their outcome.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2017

Funding Scheme: Postgraduate Scholarships

Funding Amount: $172,126.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Central Nervous System

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Parkinson disease | antibody | autoimmunity | dopamine | dopamine receptors | encephalopathy | movement disorders | neuroimmunology | neuroinflammation | parkinsonism

Related Links